Up-regulation of interleukin 33 and soluble ST2 serum levels in liver failure

Journal of Surgical Research

Volumn 163, Issue 2, 2010, Pages

  Roth, Georg A ^a   Zimmermann, Matthias ^a   Lubsczyk, Barbara A ^a   Pilz, Johannes ^a   Faybik, Peter ^a   Hetz, Hubert ^a   Hacker, Stefan ^a   Mangold, Andreas ^a   Bacher, Andreas ^a   Krenn, Claus G ^a   Ankersmit, Hendrik Jan ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

acute liver failure; acute on chronic liver failure; chronic liver failure; cytokines; IL 33; soluble ST2

Indexed keywords

ALANINE AMINOTRANSFERASE; INTERLEUKIN 33; PROTEIN; SOLUBLE ST2 PROTEIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; IL1RL1 PROTEIN, HUMAN; IL33 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTENSIVE CARE UNIT; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; UPREGULATION; ADOLESCENT; BLOOD; HEART FAILURE; IMMUNOLOGY; MIDDLE AGED; TH2 CELL;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; FEMALE; HEART FAILURE; HUMANS; INTERLEUKINS; LIVER FAILURE; MALE; MIDDLE AGED; RECEPTORS, CELL SURFACE; TH2 CELLS; UP-REGULATION;

EID: 77956918408     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.04.004     Document Type: Article

References (22)

1. Polson J, Lee WM. AASLD position paper: The management of acute liver failure. Hepatology 2005;41:1179.
2. Rolando N, Wade J, Davalos M, et al. The systemic inflammatory response syndrome in acute liver failure.Hepatology 2000;32:734.
3. Guo LM, Liu JY, Xu DZ, et al. Application of molecular adsorbents recirculating system to removeNOand cytokines in severe liver failure patients with multiple organ dysfunction syndrome. Liver Int 2003;23(Suppl 3):16.
4. Roth GA, Faybik P, Hetz H, et al. Pro-inflammatory interleukin-18 and caspase-1 serum levels in liver failure are unaffected by MARS treatment. Dig Liver Dis 2009;41:417.
5. Moussion C, Ortega N, Girard JP. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo:Anovel "alarmin"? PloSOne2008;3:e3331.
6. Schmitz J,Owyang A, OldhamE, et al. IL-33,aninterleukin-1-like cytokine that signals via the IL-1 receptor-related proteinST2 and induces T helper type 2-associated cytokines. Immunity 2005;23:479.
7. Brunner M, Krenn C, Roth G, et al. Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intensive Care Med 2004;30:1468.
8. Becerra A, Warke RV, de Bosch N, et al. Elevated levels of soluble ST2 protein in dengue virus infected patients. Cytokine 2008;41:114.
9. Bone RC, Balk RA, Cerra FB, et al. American-College of Chest Physicians Society of Critical Care Medicine Consensus Conference-Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis. Crit Care Med 1992;20:864.
10. Miyake Y, Iwasaki Y, Terada R, et al. Systemic inflammatory response syndrome strongly affects the prognosis of patients with fulminant hepatitis B. J Gastroenterol 2007;42:485.
11. Shawcross DL, Davies NA, Williams R, et al. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 2004;40:247.
12. Sekiyama KD, Yoshiba M, Thomson AW. Circulating proinflammatory cytokines (IL-1b, TNF-a, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol 1994;98:71.
13. Gramenzi A, Andreone P, Loggi E, et al. Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection. J Viral Hepatitis 2005;12:525.
14. Coutinho HM, Acosta LP, Wu HW, et al. Th2 cytokines are associated with persistent hepatic fibrosis in human Schistosoma japonicum infection. J Infect Dis 2007;195:288.
15. Armbrust T, Batusic D, Ringe B, et al. Mast cells distribution in human liver disease and experimental rat liver fibrosis. Indications for mast cell participation in development of liver fibrosis. J Hepatol 1997;26:1042.
16. Marvie P, Lisbonne M, L'Helgoualc'h A, et al. Interleukin-33 overexpression is associated with liver fibrosis in mice and humans. J Cell Mol Med 2009 Jun 5 [Epub ahead of print].
17. Tominaga S, Kuroiwa K, Tago K, et al. Presence and expression of a novel variant form of ST2 gene product in human leukemic cell line UT-7/GM. Biochem Biophys Res Commun 1999;264:14.
18. Brint EK, Xu D, Liu H, et al. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol 2004;5:373.
19. Kumar S, Tzimas MN, Griswold DE, et al. Expression of ST2, an interleukin-1 receptor homologue, is induced by proinflammatory stimuli. Biochem Biophys Res Commun 1997;235:474.
20. Oshikawa K, Yanagisawa K, Tominaga S, et al. ST2 protein induced by inflammatory stimuli can modulate acute lung inflammation. Biochem Biophys Res Commun 2002;299:18.
21. Leung BP, Xu D, Culshaw S, et al. A novel therapy of murine collagen-induced arthritis with soluble T1/ST2. J Immunol 2004;173:145.
22. Tajima S, Oshikawa K, Tominaga S, et al. The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis. Chest 2003;124:1206.